Empagliflozin API

Holiness Pharmaceutical Ltd is a trusted and leading supplier, exporter of Empagliflozin API, supplying high-quality antidiabetic APIs to pharmaceutical companies across 40+ international markets. Empagliflozin is an SGLT-2 inhibitor widely used in the management of Type-2 Diabetes Mellitus and cardiovascular risk reduction, making us a reliable Empagliflozin bulk API supplier from India.

Globally, Holiness Pharmaceutical is recognized among reputable Empagliflozin API manufacturers, offering high assay purity, strict impurity control, excellent stability, and consistent batch-to-batch quality suitable for regulated oral antidiabetic formulations. Our expertise in complex diabetes-care molecules positions us as a dependable Pharmaceutical API exporter.

Our API manufacturing facilities operate in strict compliance with international pharmaceutical regulatory standards including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP guidelines,
ensuring validated synthesis routes, robust impurity profiling, and full pharmacopeial compliance for Empagliflozin API.

We export Empagliflozin API from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting formulation manufacturers producing advanced antidiabetic therapies. Holiness Pharmaceutical is widely trusted as a bulk Empagliflozin API supplier.

Holiness Pharmaceutical is one of the leading producers of Active Pharmaceutical Ingredients (APIs) and Intermediates, delivering GMP-compliant manufacturing systems, consistent product quality, and globally accepted regulatory documentation as a certified Pharmaceutical API exporter.

Holiness Pharmaceutical Ltd manages the complete lifecycle of API development — including R&D innovation, antidiabetic synthesis, commercial-scale manufacturing, quality assurance, and worldwide API distribution.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.